Kotak Healthcare Fund - Growth - Regular Plan

  • Previous Nav

  • Net Change on 23-05-2024

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The investment objective of the scheme is to seek to generate long term capital appreciation throughinvesting in equity and equity related securities of companies benefitting directly or indirectly Pharma, Healthcare, and allied sectors.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
Nifty Healthcare Index - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 56.61 14.69 25.16 1.82 7,132.82
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option Jul 13, 2018 60.81 16.45 26.25 1.95 3,834.82
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH Jul 14, 1999 51.37 15.65 25.35 2.01 2,667.21
DSP Healthcare Fund - Regular Plan - Growth Nov 30, 2018 52.35 16.49 27.30 2.00 2,343.94
Mirae Asset Healthcare Fund -Regular Growth Jul 02, 2018 52.98 14.05 25.73 1.99 2,236.01

Fund Holdings as on 30-April-2024

  • SUN PHARMACEUTICAL INDUSTRIES LTD.

  • Cipla Ltd.

  • Dr.Reddy's Laboratories Ltd.

  • Zydus Lifesciences Ltd.

  • Max Healthcare Institute Ltd.

  • Divis Laboratories Ltd.

  • Alkem Laboratories Ltd.

  • Torrent Pharmaceuticals Ltd.

  • MANKIND PHARMA LTD

  • JB Chemicals & Pharmaceuticals Ltd.

  • Ajanta Pharma Ltd.

  • Triparty Repo

  • INNOVA CAPTABS LTD

  • Apollo Hospitals Enterprise Ltd.

  • Marksans Pharma Ltd

  • Laurus Labs Ltd

  • IPCA Laboratories Ltd.

  • Max Financial Services Ltd

  • Metropolis Healthcare Ltd.

  • KRISHNA INSTITUTE OF MEDICAL

  • Fortis Healthcare India Ltd

  • Global Health Ltd.

  • GPT HEALTHCARE LIMITED

  • MEDI ASSIST HEALTHCARE SERVICES LIMITED

  • Narayana Hrudalaya Ltd

  • Gland Pharma Limited

  • Biocon Ltd.

  • Alembic Pharmaceuticals Ltd.

  • Net Current Assets/(Liabilities)

View More
  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Miscellaneous

  • Finance - Others

  • Business Support

View More

Fund Manager

  • Education:B. Tech, M.Tech, PGDM
  • Experience:17
  • Basic Details:Mr. Dhananjay Tikariha has overall 17 years of experience in Equity Research, Fund Management and Project Finance. Prior to joining KMAMC, he has also worked at IDFC Ltd.
  • Funds Managed:
  • Kotak Healthcare Fund
  • Cash

  • Equity

View More

About Kotak Healthcare Fund

Scheme Analysis

Kotak Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to Kotak Mahindra Mutual Fund. It was launched on 11-Dec-2023 and currently has an AUM of ₹290.95 crore. Kotak Healthcare Fund is benchmarked against Nifty Healthcare Index - TRI as primary index.

The NAV of Kotak Healthcare Fund ended down ₹-0.03(-0.29%)yesterday to ₹11.39.

Among its top 3 holdings the fund has exposure to SUN PHARMACEUTICAL INDUSTRIES LTD., and

The Kotak Healthcare Fund is managed by Abhishek Bisen and Shibani Kurian.

Fund House Contact

27 BKC, C-27, G Block, Bandra Kurla Complex, Bandra (E), Mumbai - 400 051

+91 (22) 66384400
mutual@kotak.com
+91 (22) 66384455